Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee

ClinicalTrials.gov ID: NCT04683627

Public ClinicalTrials.gov record NCT04683627. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 6:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy and Safety of HP-5000 Topical System (Patch) in Subjects With Osteoarthritis Pain of the Knee

Study identification

NCT ID
NCT04683627
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Noven Pharmaceuticals, Inc.
Industry
Enrollment
370 participants

Conditions and interventions

Interventions

  • Diclofenac sodium active topical patch Drug
  • Placebo patch Drug

Drug

Eligibility (public fields only)

Age range
40 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 28, 2020
Primary completion
Jul 17, 2022
Completion
Jul 24, 2022
Last update posted
Sep 3, 2025

2020 – 2022

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
Applied Research Center of Arkansas Little Rock Arkansas 72212
Clinical Research of West Florida,Inc. Clearwater Florida 33765
Universal Axon Clinical Research, LLC Doral Florida 33166
The Arthritis and Diabetes Clinic, Inc. Monroe Louisiana 71203
Noven Pharmaceuticals, Inc. Jersey City New Jersey 07310
Velocity Clinical Research Cincinnati Ohio 45242
Partners in Clinical Research Cumberland Rhode Island 02864
Palmetto Clinical Research Summerville South Carolina 29485
Metroplex Clinical Research Center Dallas Texas 75231
Quality Research Inc. San Antonio Texas 78209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04683627, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 3, 2025 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04683627 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →